MicroRNA-874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma

被引:16
作者
Tang, Wei [1 ]
Wang, Weiguang [1 ]
Zhao, Yuchi [1 ]
Zhao, Zhongyuan [1 ]
机构
[1] Yantaishan Hosp, Dept Orthoped, 91 Jiefang Rd, Yantai 264000, Shandong, Peoples R China
关键词
microRNA-874; osteosarcoma; cyclin-dependent kinase 9; proliferation; invasion; CDK9; INHIBITOR; IN-VIVO; CANCER; EXPRESSION; GROWTH; PROGRESSION; METASTASIS; CARCINOMA; NETWORKS; MIR-874;
D O I
10.3892/ol.2018.8294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) perform important roles in the development and progression of human malignancy. miR-874, as a tumor suppressor, is decreased in malignant tumors, including osteosarcoma. However, the potential mechanism of miR-874 in osteosarcoma remains largely unknown. In the present study, a dual-luciferase reporter system supported cyclin-dependent kinase 9 (CDK9) as a direct target gene of miR-874. miR-874 mimics evidently repressed CDK9 expression in osteosarcoma. Furthermore, osteosarcoma tissues and cell lines exhibited increased expression of CDK9, and CDK9 expression levels were inversely correlated (R= -0.725) with that of miR-874 in osteosarcoma tissues. Finally, CDK9 overexpression reversed the potential effect of miR-874 on the proliferation and invasion of osteosarcoma cells. Overall, the results revealed that miR-874, as a tumor suppressor, is involved in osteosarcoma progression and metastasis by targeting CDK9, indicating that the miR-874/CDK9 pathway may serve as a potential therapeutic target for the treatment of osteosarcoma.
引用
收藏
页码:7649 / 7654
页数:6
相关论文
共 22 条
  • [1] CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2
    Garriga, J
    Bhattacharya, S
    Calbó, J
    Marshall, RM
    Truongcao, M
    Haines, DS
    Graña, X
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (15) : 5165 - 5173
  • [2] CDK9 Regulates AR Promoter Selectivity and Cell Growth through Serine 81 Phosphorylation
    Gordon, Vicki
    Bhadel, Shriti
    Wunderlich, Winfried
    Zhang, JoAnn
    Ficarro, Scott B.
    Mollah, Sahana A.
    Shabanowitz, Jeffrey
    Hunt, Donald F.
    Xenarios, Ioannis
    Hahn, William C.
    Conaway, Mark
    Carey, Michael F.
    Gioeli, Daniel
    [J]. MOLECULAR ENDOCRINOLOGY, 2010, 24 (12) : 2267 - 2280
  • [3] microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R
    Han, Kang
    Zhao, Tingbao
    Chen, Xiang
    Bian, Na
    Yang, Tongtao
    Ma, Qiong
    Cai, Chengkui
    Fan, Qingyu
    Zhou, Yong
    Ma, Baoan
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1437 - 1449
  • [4] miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer
    Jiang, Baofei
    Li, Zengliang
    Zhang, Wenjie
    Wang, Haixiao
    Zhi, Xiaofei
    Feng, Jin
    Chen, Zheng
    Zhu, Yi
    Yang, Li
    Xu, Hao
    Xu, Zekuan
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 1011 - 1025
  • [5] Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer
    Kesanakurti, Divya
    Maddirela, Dilip Rajasekhar
    Chittivelu, Subramanyam
    Rao, Jasti S.
    Chetty, Chandramu
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (03) : 627 - 633
  • [6] Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
    Krystof, Vladimir
    Baumli, Sonja
    Fuerst, Robert
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (20) : 2883 - 2890
  • [7] Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma
    Li, X.
    Yang, H.
    Tian, Q.
    Liu, Y.
    Wang, M.
    Ye, Z.
    Weng, Y. X.
    [J]. NEOPLASMA, 2014, 61 (04) : 453 - 460
  • [8] CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol
    Liu, Xiangrui
    Shi, Shenhua
    Lam, Frankie
    Pepper, Chris
    Fischer, Peter M.
    Wang, Shudong
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (05) : 1216 - 1226
  • [9] Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
    Livak, KJ
    Schmittgen, TD
    [J]. METHODS, 2001, 25 (04) : 402 - 408
  • [10] CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression
    Mitra, Partha
    Yang, Ren-Ming
    Sutton, James
    Ramsay, Robert G.
    Gonda, Thomas J.
    [J]. ONCOTARGET, 2016, 7 (08) : 9069 - 9083